Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: Implications for chemotherapy

Journal of Neuro-Oncology

Volumn 104, Issue 1, 2011, Pages 11-19

  Joshi, Shailendra ^a   Ergin, Aysegul ^b   Wang, Mei ^a   Reif, Roberto ^b   Zhang, Jane ^c   Bruce, Jeffrey N ^d   Bigio, Irving J ^c  

^a Columbia University ^*  (United States)

^b Boston University   (United States)

^c BOSTON UNIVERSITY   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Blood brain barrier disruption; Intraarterial; Mannitol

Indexed keywords

EVANS BLUE; MANNITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD BRAIN BARRIER DISRUPTION; BLOOD PRESSURE; BRAIN TISSUE; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG MONITORING; DRUG UPTAKE; FEASIBILITY STUDY; HEART RATE; NONHUMAN; PARTITION COEFFICIENT; RABBIT;

ANIMALS; BLOOD PRESSURE; BLOOD-BRAIN BARRIER; BRAIN; BRAIN WAVES; ELECTROENCEPHALOGRAPHY; EVANS BLUE; HEART RATE; HEMODYNAMICS; INJECTIONS, INTRA-ARTERIAL; LASER-DOPPLER FLOWMETRY; MANNITOL; RABBITS; SWEETENING AGENTS; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 80052746484     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0466-4     Document Type: Article

References (50)

1. E Neuwelt NJ Abbott L Abrey, et al. 2008 Strategies to advance translational research into brain barriers Lancet Neurol 7 84 96 18093565 10.1016/S1474-4422(07)70326-5 1:CAS:528:DC%2BD1cXhtlaqtbo%3D (Pubitemid 350258701)
2. TN Nagaraja KA Keenan JD Fenstermacher RA Knight 2008 Acute leakage patterns of fluorescent plasma flow markers after transient focal cerebral ischemia suggest large openings in blood-brain barrier Microcirculation 15 1 14 17934962 10.1080/10739680701409811 1:CAS:528:DC%2BD1cXltVyruw%3D%3D
3. KL Black T Cloughesy SC Huang, et al. 1997 Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas J Neurosurg 86 603 609 9120622 10.3171/jns.1997.86.4.0603 1:CAS:528:DyaK2sXisV2lu7Y%3D (Pubitemid 27138628)
4. AK Bhattacharjee T Kondoh T Nagashima, et al. 2001 Quantitative analysis of papaverine-mediated blood-brain barrier disruption in rats Biochem Biophys Res Commun 289 548 552 11716508 10.1006/bbrc.2001.6029 1:CAS:528: DC%2BD3MXosFGiu7c%3D (Pubitemid 33141089)
5. TF Cloughesy KL Black YP Gobin, et al. 1999 Intra-arterial Cereport (RMP-7) and carboplatin: a dose escalation study for recurrent malignant gliomas Neurosurgery 44 270 278 9932880 10.1097/00006123-199902000-00015 1:STN:280:DyaK1M7ivFKlsg%3D%3D (discussion 278-279) (Pubitemid 29068170)
6. HJ Lee Y Zhang WM Pardridge 2002 Blood-brain barrier disruption following the internal carotid arterial perfusion of alkyl glycerols J Drug Target 10 463 467 12575736 10.1080/1061186021000038337 1:CAS:528:DC%2BD38XosFyru7s%3D (Pubitemid 35230196)
7. GR Neufeld 1971 Computation of transit time distributions using sampled data Laplace transforms J Appl Physiol 31 148 153 4933900 1:STN:280: DyaE3M3ktVKrsw%3D%3D
8. E Zylber-Katz JM Gomori A Schwartz, et al. 2000 Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma Clin Pharmacol Ther 67 631 641 10872645 10.1067/mcp.2000.106932 1:CAS:528:DC%2BD3cXltFSitb8%3D (Pubitemid 30416079)
9. ND Doolittle ME Miner WA Hall, et al. 2000 Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors Cancer 88 637 647 10649259 10.1002/(SICI)1097-0142(20000201)88: 3<637::AID-CNCR22>3.0.CO;2-Y 1:STN:280:DC%2BD3c7hsFeksg%3D%3D (Pubitemid 30056941)
10. MA Bellavance M Blanchette D Fortin 2008 Recent advances in blood-brain barrier disruption as a CNS delivery strategy AAPS J 10 166 177 18446517 10.1208/s12248-008-9018-7 1:CAS:528:DC%2BD1cXhtVWrsLvN
11. N Marchi L Angelov T Masaryk, et al. 2007 Seizure-promoting effect of blood-brain barrier disruption Epilepsia 48 732 742 17319915 10.1111/j.1528-1167.2007.00988.x 1:CAS:528:DC%2BD2sXlsVWgsb0%3D (Pubitemid 46587627)
12. NM Elkassabany J Bhatia A Deogaonkar, et al. 2008 Perioperative complications of blood brain barrier disruption under general anesthesia: a retrospective review J Neurosurg Anesthesiol 20 45 48 18157025 10.1097/ANA.0b013e31815d5f1f (Pubitemid 351628039)
13. 2, and other factors on osmotic blood-brain barrier disruption in rats with brain tumor xenografts Anesth Analg 88 559 567 10072006 1:CAS:528:DyaK1MXhvVGnsLc%3D (Pubitemid 29109022)
14. JR Mourant TM Johnson G Los IJ Bigio 1999 Non-invasive measurement of chemotherapy drug concentrations in tissue: preliminary demonstrations of in vivo measurements Phys Med Biol 44 1397 1417 10368027 10.1088/0031-9155/44/5/322 1:CAS:528:DyaK1MXjsFaqu7w%3D (Pubitemid 29225668)
15. IJ Bigio JR Mourant 1997 Ultraviolet and visible spectroscopies for tissue diagnostics: fluorescence spectroscopy and elastic-scattering spectroscopy Phys Med Biol 42 803 814 9172260 10.1088/0031-9155/42/5/005 1:STN:280:DyaK2szhs1egsA%3D%3D (Pubitemid 27263501)
16. IJ Bigio JR Mourant G Los 1999 Noninvasive, in situ measurement of drug concentrations in tissue using optical spectroscopy J Gravit Physiol 6 P173 P175 11543008 1:STN:280:DC%2BD3MnmtFGruw%3D%3D
17. R Reif M Wang S Joshi, et al. 2007 Optical method for real-time monitoring of drug concentrations facilitates the development of novel methods for drug delivery to brain tissue J Biomed Opt 12 034036 17614744 10.1117/1.2744025 (Pubitemid 47249798)
18. SC Kanick JL Eiseman E Joseph, et al. 2007 Noninvasive and nondestructive optical spectroscopic measurement of motexafin gadolinium in mouse tissues: comparison to high-performance liquid chromatography J Photochem Photobiol B 88 90 104 17604637 10.1016/j.jphotobiol.2007.05.002 1:CAS:528:DC%2BD2sXhtVCmt7vE (Pubitemid 47382612)
19. M Wang J Etu S Joshi 2007 Enhanced disruption of the blood brain barrier by intracarotid mannitol injection during transient cerebral hypoperfusion in rabbits J Neurosurg Anesthesiol 19 249 256 17893577 10.1097/ANA.0b013e3181453851 (Pubitemid 47480717)
20. S Joshi M Wang R Hartl 2004 Retinal discoloration test J Cereb Blood Flow Metab 24 305 308 15091111 10.1097/01.WCB.0000107731.66603.18 (Pubitemid 38314586)
21. S Joshi M Wang EV Nishanian RG Emerson 2004 Electrocerebral silence by intracarotid anesthetics does not affect early hyperemia after transient cerebral ischemia in rabbits Anesth Analg 98 1454 1459 15105230 10.1213/01.ANE.0000112320.77816.FA (table of contents) (Pubitemid 38525608)
22. JS Lee MG Hamilton JM Zabramski 1994 Variations in the anatomy of the rabbit cervical carotid artery Stroke 25 501 503 8303763 10.1161/01.STR.25.2.501 1:STN:280:DyaK2c7jsFyjsg%3D%3D (Pubitemid 24047283)
23. BA Perkins LJ Strausbaugh 1983 Effect of mannitol infusions into the internal carotid artery on entry of two antibiotics into the cerebrospinal fluid and brains of normal rabbits Antimicrob Agents Chemother 24 339 342 6416160 1:CAS:528:DyaL3sXlvVKqu70%3D (Pubitemid 13007344)
24. M Wang S Joshi 2002 Comparison of intravenous and intracarotid propofol for electrical silence on EEG J Neurosurg Anesthesiol 14 333 10.1097/00008506-200210000-00014 1:CAS:528:DC%2BD3sXisVWnurs%3D
25. LJ Strausbaugh 1987 Intracarotid infusions of protamine sulfate disrupt the blood-brain barrier of rabbits Brain Res 409 221 226 3580873 10.1016/0006-8993(87)90705-0 1:CAS:528:DyaL2sXktFOmur0%3D (Pubitemid 17077541)
26. X Chen JW Gawryluk JF Wagener, et al. 2008 Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease J Neuroinflamm 5 12 10.1186/1742-2094-5-12 (Pubitemid 351597460)
27. JM Provenzale S Mukundan M Dewhirst 2005 The role of blood-brain barrier permeability in brain tumor imaging and therapeutics AJR Am J Roentgenol 185 763 767 16120931 10.2214/AJR.05.0782
28. OZ Chi X Liu HR Weiss 2001 Effects of mild hypothermia on blood-brain barrier disruption during isoflurane or pentobarbital anesthesia Anesthesiology 95 933 938 11605935 10.1097/00000542-200110000-00023 1:CAS:528: DC%2BD3MXnvVChtb4%3D (Pubitemid 32939118)
29. MK Gumerlock EA Neuwelt 1990 The effects of anesthesia on osmotic blood-brain barrier disruption Neurosurgery 26 268 277 2308675 10.1227/00006123-199002000-00014 1:STN:280:DyaK3c7nsVeksw%3D%3D (Pubitemid 20091252)
30. OZ Chi TW Chun X Liu HR Weiss 1998 The effects of pentobarbital on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats Anesth Analg 86 1230 1235 9620510 1:CAS:528:DyaK1cXjvVals78%3D (Pubitemid 28249242)
31. DE Bullard M Bourdon DD Bigner 1984 Comparison of various methods for delivering radiolabeled monoclonal antibody to normal rat brain J Neurosurg 61 901 911 6436447 10.3171/jns.1984.61.5.0901 1:STN:280:DyaL2M%2Fjt1ymuw%3D%3D (Pubitemid 15203741)
32. G Mychaskiw II AE Badr R Tibbs, et al. 2000 Optison (FS069) disrupts the blood-brain barrier in rats Anesth Analg 91 798 803 11004029 10.1097/00000539-200010000-00007 1:CAS:528:DC%2BD3cXnt1Oruro%3D
33. M Wolf M Ferrari V Quaresima 2007 Progress of near-infrared spectroscopy and topography for brain and muscle clinical applications J Biomed Opt 12 062104 18163807 10.1117/1.2804899
34. M Ueno 2007 Molecular anatomy of the brain endothelial barrier: an overview of the distributional features Curr Med Chem 14 1199 1206 17504140 10.2174/092986707780597943 1:CAS:528:DC%2BD2sXltFejsrs%3D (Pubitemid 46739321)
35. HA Riina JF Fraser S Fralin, et al. 2009 Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma J Exp Ther Oncol 8 145 150 20192120 1:CAS:528: DC%2BC3cXhvFahtbo%3D
36. GL Baumbach WG Mayhan DD Heistad 1986 Protection of the blood-brain barrier by hypercapnia during acute hypertension Am J Physiol 251 H282 H287 3740284 1:STN:280:DyaL283ptleltg%3D%3D
37. P Ballabh A Braun M Nedergaard 2004 The blood-brain barrier: an overview: structure, regulation, and clinical implications Neurobiol Dis 16 1 13 15207256 10.1016/j.nbd.2003.12.016 1:CAS:528:DC%2BD2cXjs1altL8%3D (Pubitemid 38569790)
38. H Al-Sarraf F Ghaaedi Z Redzic 2007 Time course of hyperosmolar opening of the blood-brain and blood-CSF barriers in spontaneously hypertensive rats J Vasc Res 44 99 109 17191032 10.1159/000098260 1:CAS:528:DC%2BD2sXhvVSms7w%3D
39. J van Horssen BP Brink HE de Vries, et al. 2007 The blood-brain barrier in cortical multiple sclerosis lesions J Neuropathol Exp Neurol 66 321 328 17413323 10.1097/nen.0b013e318040b2de (Pubitemid 46559025)
40. D Soon DJ Tozer DR Altmann, et al. 2007 Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes Mult Scler 13 884 894 17468443 10.1177/1352458507076970 1:STN:280:DC%2BD2srmtVWlsQ%3D%3D (Pubitemid 351540860)
41. Ruda R, Trevisan E, Soffietti R (2010) Epilepsy and brain tumors. Curr Opin Oncol 22(6):611-620
42. R Kalayci M Kaya B Ahishali, et al. 2006 Long-term L-NAME treatment potentiates the blood-brain barrier disruption during pentylenetetrazole-induced seizures in rats Life Sci 79 16 20 16438992 10.1016/j.lfs.2005.12.034 1:CAS:528:DC%2BD28Xks1Wru78%3D (Pubitemid 44255531)
43. RC Brown TP Davis 2002 Calcium modulation of adherens and tight junction function: a potential mechanism for blood-brain barrier disruption after stroke Stroke 33 1706 1711 12053015 10.1161/01.STR.0000016405.06729.83 1:CAS:528:DC%2BD38Xltlaktbo%3D (Pubitemid 34619982)
44. EA Neuwelt PA Barnett FL Ramsey, et al. 1993 Dexamethasone decreases the delivery of tumor-specific monoclonal antibody to both intracerebral and subcutaneous tumor xenografts Neurosurgery 33 478 484 8413880 10.1227/00006123-199309000-00018 1:STN:280:DyaK2c%2FitVWgtw%3D%3D (discussion 484) (Pubitemid 23260756)
45. AG Euser L Bullinger MJ Cipolla 2008 Magnesium sulphate treatment decreases blood-brain barrier permeability during acute hypertension in pregnant rats Exp Physiol 93 254 261 17933863 10.1113/expphysiol.2007.039966 1:CAS:528:DC%2BD1cXivFKktrY%3D
46. AK Bhattacharjee T Nagashima T Kondoh N Tamaki 2001 The effects of the Na(+)/Ca(++) exchange blocker on osmotic blood-brain barrier disruption Brain Res 900 157 162 11334793 10.1016/S0006-8993(01)02253-3 1:CAS:528: DC%2BD3MXjtFGisr4%3D (Pubitemid 32382107)
47. T Siegal R Rubinstein F Bokstein, et al. 2000 In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans J Neurosurg 92 599 605 10761648 10.3171/jns.2000.92.4.0599 1:STN:280: DC%2BD3c3it1artw%3D%3D (Pubitemid 30180664)
48. KM Boje SS Lakhman 2000 Nitric oxide redox species exert differential permeability effects on the blood-brain barrier J Pharmacol Exp Ther 293 545 550 10773027 1:CAS:528:DC%2BD3cXkvFWgtrk%3D (Pubitemid 30244106)
49. KM Boje 1996 Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis Brain Res 720 75 83 8782899 10.1016/0006-8993(96)00142-4 1:CAS:528:DyaK28Xjs1Sjs7o%3D (Pubitemid 26179818)
50. RC Brown RD Egleton TP Davis 2004 Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin Brain Res 1014 221 227 15213006 10.1016/j.brainres.2004.04.034 1:CAS:528:DC%2BD2cXltVChurY%3D (Pubitemid 38798466)